Quantitative Evaluation and Prognostic Study of Myocardial Iron Overload in Patients with Thalassemia by Cardiac Magnetic Resonance Imaging

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400092421

Enrollment

Unknown

Registered

2024-11-15

Start date

2024-11-20

Completion date

Unknown

Last updated

2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thalassemia

Interventions

Iron chelation therapy group:NA

Untreated group:NA

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-70 years old; 2. Patients with regular, long-term blood transfusion program.

Exclusion criteria

Exclusion criteria: 1. Patients with previous diagnosis of diabetes, or meet the diagnostic criteria for diabetes at the time of visit 2. Patients with previous cardiovascular diseases, lung diseases, thrombotic diseases, tumors, et al 3. Patients with iron deficiency 4. Patients who are unable to cooperate with the study

Design outcomes

Primary

Measure	Time frame
The degree of iron overload in the heart;	—

Secondary

Measure	Time frame
The degree of myocardial fibrosis;The severity of myocardial iron overload;Left ventricular ejection fraction;	—

Countries

China

Contacts

Public ContactYajie Dong

The First Affiliated Hospital of Kunming Medical University

1152587607@qq.com+86 136 9871 7806

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026